how common is pancreatitis with semaglutide GLP-1 Agonists and Risk Small risk of severe acute

If the medication stops and the surrounding habits stay the same, weight regain can happen, so I want patients to use this period to build habits that can hold up over time

For instance, studies have reported an average weight loss of approximately 21% among Tirzepatide users, compared to 15% for Semaglutide

Want to support your cellular health for added benefits

Results of more studies testing the SGLT-2 inhibitor sotagliflozin in people with type 1 diabetes, continued to be encouraging: Sotagliflozin reduced A1C and body weight, lowered insulin doses, and caused fewer episodes of severe hypoglycemia compared to control groups

What to do next: Include a protein portion in every meal

If your dosing schedule means you will not use all the medication in a multi-dose vial within 28 days, talk to your provider about whether a different vial size or concentration would reduce waste